← Back to Search

Dietary Supplement

Dietary supplement arm for High-Density Lipoprotein

N/A

Waitlist Available

Led By Mark Houston, MD

Research Sponsored by Metagenics, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0 - week 12

Awards & highlights

Study Summary

This trial evaluates a nutritional supplement for safety, tolerance, and acceptability. It also looks at the supplement's potential to improve quality of life.

Eligible Conditions

High-Density Lipoprotein
Well-being

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0 - week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0 - week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 - week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Frequency of participant adverse events during the supplementation period

Secondary outcome measures

Concentration of HDL-C

Concentration of MPO

Concentration of hsCRP

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Dietary supplement armExperimental Treatment1 Intervention

Subjects to receive a specific dietary supplement

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Dietary supplementation

2011

N/A

~200

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Hypertension Institute, NashvilleOTHER

2 Previous Clinical Trials

122 Total Patients Enrolled

Metagenics, Inc.Lead Sponsor

14 Previous Clinical Trials

1,406 Total Patients Enrolled

Mark Houston, MDPrincipal InvestigatorHypertension Institute

2 Previous Clinical Trials

95 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For whom is this clinical assessment available?

"To be considered for participation, applicants must have a cholesterol level within the expected range and an HDL that is similarly in line with expectations. Additionally, they should fall between 18 to 85 years old. This trial has room for around 10 patients."

Answered by AI

Does this research project accept volunteers who are 20 or older?

"As per the rules of this clinical trial, individuals aged 18-85 are eligible to apply."

Answered by AI

Is the recruitment of participants currently ongoing for this trial?

"According to the clinicaltrials.gov registry, this study is no longer actively seeking participants; it was first posted on September 18th 2019 and last updated on April 4th 2022. However, there are still 13 other trials that are presently recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HDL Function Dietary Supplement Safety and QOL

2019. "HDL Function Dietary Supplement Safety and QOL". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04097119.